{"protocolSection":{"identificationModule":{"nctId":"NCT03864484","orgStudyIdInfo":{"id":"H30-038"},"organization":{"fullName":"Kibi International University","class":"OTHER"},"briefTitle":"iPad Application-based Intervention for Post-stroke Depression","officialTitle":"An iPad Application-based Intervention for Improving Post-stroke Depression Symptoms: A Pilot Randomized Controlled Trial"},"statusModule":{"statusVerifiedDate":"2020-08","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-05-07","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-03-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2022-03-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-03-02","studyFirstSubmitQcDate":"2019-03-04","studyFirstPostDateStruct":{"date":"2019-03-06","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-08-31","lastUpdatePostDateStruct":{"date":"2020-09-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Kazuki Hirao, PhD, OT","investigatorTitle":"Assistant Professor","investigatorAffiliation":"Kibi International University"},"leadSponsor":{"name":"Kibi International University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"We plan to conduct a randomized controlled trial to examine whether usual rehabilitation plus an iPad application-based intervention improves post-stroke depression symptoms compared to usual rehabilitation alone.\n\nThe purpose of this pilot randomized controlled trial is to investigate the feasibility of the final randomized controlled trial."},"conditionsModule":{"conditions":["Post-stroke Depression"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":32,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"iPad Application + Usual Rehabilitation","type":"EXPERIMENTAL","description":"The experimental group receives usual rehabilitation. In addition, participants watch a video using the iPad Application displaying positive word stimuli.","interventionNames":["Device: iPad Application + Usual Rehabilitation"]},{"label":"Usual rehabilitation","type":"ACTIVE_COMPARATOR","description":"The control group receives usual rehabilitation.","interventionNames":["Behavioral: Usual rehabilitation"]}],"interventions":[{"type":"DEVICE","name":"iPad Application + Usual Rehabilitation","description":"The experimental group receives usual rehabilitation. In addition, the experimental group will watch movies using the iPad application for 3 minutes, once daily for 5 weeks.","armGroupLabels":["iPad Application + Usual Rehabilitation"]},{"type":"BEHAVIORAL","name":"Usual rehabilitation","description":"The control group receives usual rehabilitation.","armGroupLabels":["Usual rehabilitation"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Depression severity as measured by the Center for Epidemiologic Studies Depression Scale (CES-D) score.","timeFrame":"Change from Baseline CES-D at 5 weeks"}],"secondaryOutcomes":[{"measure":"Health-related quality of life as measured by the 36-item short-form Medical Outcome Study Questionnaire (SF-36).","timeFrame":"Change from Baseline SF-36 at 5 weeks"},{"measure":"Activities of daily living as measured by Functional Independence Measure (FIM).","timeFrame":"Change from Baseline FIM at 5 weeks"},{"measure":"Dynamic standing balance as measured by Functional Reach Test (FRT).","timeFrame":"Change from Baseline FRT at 5 weeks"},{"measure":"Safety is defined as the proportion of patients who experience an intervention-related adverse event or any adverse event during the study.","description":"Adverse events, whether or not considered causally related to the study intervention, include death and life-threatening illness or injury requiring prolonged hospitalization or resulting in persistent disability.","timeFrame":"The period from the start of the intervention to 5 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 40 years and older\n* Males and females\n* Center for Epidemiologic Studies Depression Scale score ≥16\n* Mini Mental State Examination score ≥ 24\n* First stroke\n* Native language is Japanese\n* Written informed consent prior to participation\n\nExclusion Criteria:\n\n* Major depressive disorder before onset of stroke\n* Bilateral hemiplegia\n* Vision or hearing deficits that negatively impact everyday life\n* Severe aphasia\n* Severe unilateral spatial neglect\n* Diagnosis of neurodegenerative disease such as Parkinson's disease or multiple system atrophy\n* Current life-threatening severe organ failure, musculoskeletal disorders, or cancer","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Hiroyuki Uchida","role":"CONTACT","phone":"+81-86-427-1111","email":"hiroyukiuchida02@gmail.com"}],"overallOfficials":[{"name":"Kazuki Hirao, PhD","affiliation":"Kibi International University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Kurashiki Heisei Hospital","status":"RECRUITING","city":"Kurashiki","state":"Okayama","zip":"710-0826","country":"Japan","contacts":[{"name":"Hiroyuki Uchida","role":"CONTACT","phone":"+81-86-427-1111","email":"hiroyukiuchida02@gmail.com"}],"geoPoint":{"lat":34.58333,"lon":133.76667}}]},"referencesModule":{"references":[{"pmid":"34456565","type":"DERIVED","citation":"Ejiri H, Uchida H, Tsuchiya K, Fujiwara K, Kikuchi S, Hirao K. Effects of Smartphone-Delivered Positive-Word Stimulation on Depressed Mood in People with Subthreshold Depression: Protocol for a Pilot Randomized Controlled Trial. Neuropsychiatr Dis Treat. 2021 Aug 20;17:2739-2748. doi: 10.2147/NDT.S323126. eCollection 2021. Erratum In: Neuropsychiatr Dis Treat. 2021 Aug 30;17:2847-2848."}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000003863","term":"Depression"},{"id":"D000003866","term":"Depressive Disorder"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001526","term":"Behavioral Symptoms"},{"id":"D000019964","term":"Mood Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M6748","name":"Depression","asFound":"Depression","relevance":"HIGH"},{"id":"M6751","name":"Depressive Disorder","asFound":"Depression","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4508","name":"Behavioral Symptoms","relevance":"LOW"},{"id":"M21525","name":"Mood Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]}},"hasResults":false}